DYADIC INTERNATIONAL INC Proceeds from Sale of Investment Projects
DYADIC INTERNATIONAL INC (DYAI) reported Proceeds from Sale of Investment Projects of $0 for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfInvestmentProjects · last filed 2026-03-25
- DYADIC INTERNATIONAL INC proceeds from sale of investment projects for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- DYADIC INTERNATIONAL INC proceeds from sale of investment projects for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- DYADIC INTERNATIONAL INC proceeds from sale of investment projects for the quarter ending 2024-09-30 was $0.00.
- DYADIC INTERNATIONAL INC proceeds from sale of investment projects for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- DYADIC INTERNATIONAL INC proceeds from sale of investment projects for fiscal 2024 was $60.98K, a 95.30% decline from fiscal 2023.
- DYADIC INTERNATIONAL INC proceeds from sale of investment projects for fiscal 2023 was $1.30M.
- DYADIC INTERNATIONAL INC proceeds from sale of investment projects for fiscal 2022 was $0.00.
| Period end | Proceeds from Sale of Investment Projects 3 month | Proceeds from Sale of Investment Projects 6 month | Proceeds from Sale of Investment Projects 9 month | Proceeds from Sale of Investment Projects 12 month |
|---|---|---|---|---|
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $0.00 derived: sum of 3 quarters · filed 2026-03-25 | $0.00 derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $0.00 derived: sum of 3 quarters · filed 2026-03-25 | $60.98K 10-K · filed 2026-03-25 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $60.98K 10-Q · filed 2025-11-12 | $65.10K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $60.98K 10-Q · filed 2025-08-13 | $65.10K derived: sum of 3 quarters · filed 2025-08-13 | $56.34K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $60.98K 10-Q · filed 2025-05-14 | $65.10K derived: sum of 2 quarters · filed 2025-05-14 | $56.34K derived: sum of 3 quarters · filed 2025-05-14 | $84.85K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $4.12K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$4.64K derived: sum of 2 quarters · filed 2025-03-26 | $23.88K derived: sum of 3 quarters · filed 2025-03-26 | $1.30M 10-K · filed 2025-03-26 |
| 2023-09-30 | -$8.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $19.75K derived: sum of 2 quarters · filed 2024-11-12 | $1.29M 10-Q · filed 2024-11-12 | $1.29M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $28.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $1.30M 10-Q · filed 2024-08-13 | $1.30M derived: sum of 3 quarters · filed 2024-08-13 | $1.30M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $1.27M 10-Q · filed 2024-05-14 | $1.27M derived: sum of 2 quarters · filed 2024-05-14 | $1.27M derived: sum of 3 quarters · filed 2024-05-14 | $1.27M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | $0.00 10-K · filed 2024-03-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |